ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,118.40
0.00%
Dow Jones
39,721.36
1.09%
Brent Oil
85.135
0.10%
Bitcoin
58,114.04
0.62%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
10/28/20208:48AMPR Newswire (US)Robitussin Launches Their First-Ever Drug-Free Products for Cough Relief with a Cheerful CollaborationNYSE:GSKGSK plc
10/28/20202:50AMDow Jones NewsSanofi, GSK to Supply 200 Million Doses of Covid-19 Vaccine to COVAX FacilityNYSE:GSKGSK plc
10/24/202012:30AMDow Jones NewsTo Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest CompetitorsNYSE:GSKGSK plc
10/16/20207:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/14/202011:21AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/14/202011:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/202012:13PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NYSE:GSKGSK plc
10/13/202010:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/20209:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/20209:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/07/202010:33AMEdgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NYSE:GSKGSK plc
10/06/202011:55AMDow Jones NewsCovid-19 Antibody Drug From Glaxo, Vir Enters Phase 3 TestingNYSE:GSKGSK plc
10/06/20209:16AMDow Jones NewsVir Biotechnology, GlaxoSmithKline Expand to Phase 3 Study of Treatment for Covid-19NYSE:GSKGSK plc
10/06/20208:18AMGlobeNewswire Inc.Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of CO...NYSE:GSKGSK plc
10/01/20202:53PMEdgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NYSE:GSKGSK plc
10/01/20202:50PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/01/20209:05AMPR Newswire (US)ViiV Healthcare presents a new podcast about the Power of Being SeenNYSE:GSKGSK plc
09/29/20208:45AMInvestorWireDesperate Need Fuels New Products, Programs in Smoking Cessation SpaceNYSE:GSKGSK plc
09/28/20204:26PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:GSKGSK plc
09/28/20209:31AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:GSKGSK plc
09/28/20208:54AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/27/20207:30PMDow Jones NewsFirst U.K. Patient Receives Trial Drug as Treatment for Covid-19NYSE:GSKGSK plc
09/25/20205:18PMDow Jones NewsGlaxoSmithKline Gets FDA Approval for Blood-Disorder Drug NucalaNYSE:GSKGSK plc
09/25/20203:58PMBusiness WireFDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)NYSE:GSKGSK plc
09/23/20208:00AMPR Newswire (Canada)ViiV Healthcare Announces Availability of CABENUVA and VOCABRIA in CanadaNYSE:GSKGSK plc
09/23/20208:00AMPR Newswire (Canada)ViiV Soins de santé annonce que CABENUVA et VOCABRIA sont maintenant offerts au CanadaNYSE:GSKGSK plc
09/22/20201:46PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/22/20201:19PMDow Jones NewsSanofi, GSK to Supply Adjuvanted Covid-19 Vaccine to Canadian GovernmentNYSE:GSKGSK plc
09/18/20208:08AMDow Jones NewsEU Agrees to Buy Potential Sanofi, GSK Covid-19 Vaccine -- UpdateNYSE:GSKGSK plc
09/18/20207:39AMDow Jones NewsEU Agrees to Buy Potential Sanofi, GSK Covid-19 VaccineNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
AMEX
SPY
SPDR S&P 500
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved